The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals

scientific article published on 5 July 2014

The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/AJMG.B.32249
P8608Fatcat IDrelease_4y2uevnwmvcdnhpkciqiai2unu
P698PubMed publication ID25044277

P50authorMichael GillQ30388950
Derek W. MorrisQ37651969
Gary J. DonohoeQ37652405
Aiden CorvinQ37652504
Emma RoseQ42770787
Dara CannonQ43079262
Colm McdonaldQ86708914
Aine SineadQ89705817
Ciara FaheyQ114530524
P2093author name stringCathy Scanlon
P2860cites workmicroRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorderQ21184126
Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studiesQ24630012
MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1Q24630616
Voxel-based morphometry–the methodsQ28138780
A fast diffeomorphic image registration algorithmQ28243996
Genome-wide association study identifies five new schizophrenia lociQ28248384
Genetic influences on human brain structure: a review of brain imaging studies in twinsQ28297028
Advances in functional and structural MR image analysis and implementation as FSLQ29547164
Genetic influences on brain structureQ33955853
Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relativesQ34499232
Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and functionQ34620100
The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortiumQ35931582
A Bayesian model of shape and appearance for subcortical brain segmentationQ36158330
Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorderQ36323567
Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblingsQ36666237
A family affair: brain abnormalities in siblings of patients with schizophreniaQ37256194
Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritabilityQ37285460
Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disabilityQ38331099
Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137.Q43496188
The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individualsQ44293364
Nonstationary cluster-size inference with random field and permutation methodsQ44933443
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophreniaQ48140110
Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study.Q51900011
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)467-471
P577publication date2014-07-05
P1433published inAmerican Journal of Medical Genetics Part B: Neuropsychiatric GeneticsQ15762380
P1476titleThe miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals
P478volume165B

Reverse relations

cites work (P2860)
Q36994815A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression
Q50015658A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.
Q42376220Genome-Wide Supported Risk Variants in MIR137, CACNA1C, CSMD1, DRD2, and GRM3 Contribute to Schizophrenia Susceptibility in Pakistani Population
Q39143511Genomic Editing of Non-Coding RNA Genes with CRISPR/Cas9 Ushers in a Potential Novel Approach to Study and Treat Schizophrenia
Q34447816Heterogeneity and individuality: microRNAs in mental disorders
Q35940904MIR137HG risk variant rs1625579 genotype is related to corpus callosum volume in schizophrenia
Q39002120MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls
Q52320951Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia.
Q41002359The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia.

Search more.